Thomsen v. Rexall Drug & Chemical Co.

235 Cal. App. 2d 775, 45 Cal. Rptr. 642, 1965 Cal. App. LEXIS 975
CourtCalifornia Court of Appeal
DecidedJuly 19, 1965
DocketCiv. 22286
StatusPublished
Cited by21 cases

This text of 235 Cal. App. 2d 775 (Thomsen v. Rexall Drug & Chemical Co.) is published on Counsel Stack Legal Research, covering California Court of Appeal primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Thomsen v. Rexall Drug & Chemical Co., 235 Cal. App. 2d 775, 45 Cal. Rptr. 642, 1965 Cal. App. LEXIS 975 (Cal. Ct. App. 1965).

Opinion

BRAY, J. *

— Defendants, Rexall Drug and Chemical Company, and J. Mock, appeal from judgment after jury trial in favor of plaintiff in the sum of $75,000 1 the orders denying motion for nonsuit, motion for judgment notwithstanding the verdict, and motion for new trial.* 2

*777 Question Presented

Solely, the sufficiency of the evidence.

Record

The complaint charged negligence and breach of warranty in the filling of a certain prescription by defendants. A jury brought in a verdict in favor of plaintiff for $75,000 as damages for plaintiff’s injuries resulting from her taking an erroneous prescription. Judgment was entered accordingly.

Evidence

On this appeal, defendants do not attack the implied findings of negligence and breach of warranty but contend that there is insufficient evidence to show that plaintiff’s condition was proximately caused by her ingestion of the erroneously refilled prescription rather than by her preexisting illnesses or the effects of cortisone.

In the fall of 1960, plaintiff was 41 years old, married and had three children. About 15 years earlier, she began to suffer from rheumatoid arthritis, chiefly in the joints of her fingers, wrists and knees. She was placed on a steroid treatment and given cortisone drugs to alleviate the symptoms of the disease. Despite numerous flareups and remissions in her arthritic condition, she was able to take care of her family and to continue working as a waitress, earning about $90 a week. In 1956, she came under the care of Dr. Norman who prescribed many varieties of cortisone but usually returned to a type known as ataraxoid. Before seeing Dr. Norman, plaintiff had at times taken as many as seven cortisone pills a day in order to relieve her arthritic pains. Dr. Norman, however, reduced her dosage to three pills a day which was sufficient to enable her to take care of her family and to continue in her employment.

In the fall of 1960, plaintiff developed difficulty in disposing of the fluids in her body, a common symptom in patients on steroid therapy, i.e., taking cortisone type drugs. To correct this condition, Dr. Norman on September 19, 1960, prescribed a diuretic drug, with a brand name of “hydrodiuril.” On September 20, plaintiff had the original hydrodiuril prescription filled at defendant’s Drug King store on East 18th Street in Oakland across the street from her place of employment. She received a bottle containing a number of small pink pills.

On November 11, 1960, she returned for a refill of the hydrodiuril and was waited on by Mock, admittedly a reg *778 istered pharmacist in Rexall’s employ. Plaintiff noticed that Mock gave her some large yellow or white pills completely different from the small pink ones she had received before. After being assured by Mock that the white or yellow pills were her hydrodiuril prescription, plaintiff proceeded to take two pills a day in accordance with her doctor’s orders, together with her three daily pills of ataraxoid. In the latter part of November and early in December, plaintiff experienced symptoms completely different from anything she had ever felt before — an unusual muscular tiredness and weakness and a sensation of numbness in her legs.

On December 17, 1960, plaintiff returned to the defendant’s drug store for another refill of the hydrodiuril drug and the prescription was checked by another pharmacist named Farrin who informed plaintiff that the yellow or white pills were not her prescription and not to take any more of them. She returned the bottle containing some of the pills and no one ever saw them again. Farrin removed the large white or yellow pills from the bottle, changed the number on the label, and refilled it with the small pink pills that were like the original hydrodiuril pills.

In the latter part of December, plaintiff’s condition became worse. The tiredness, weakness and numbness continued until she was unable to work and became bedridden. On January 6, 1961, plaintiff went to Dr. Norman's office and told the nurse she was feeling weak and thought she had the flu. Plaintiff’s condition was preliminarily diagnosed as cortisone toxicity and she was immediately sent to St. Mary’s Hospital in San Francisco.

She remained there for one month until her transfer to the University of California Hospital. By this time, her muscular weakness, etc. had increased so that she could no longer move her arms or legs. After her release from the University of California Hospital, she was still crippled and confined to a wheelchair. Continuing physical therapy provided a slight improvement in her condition, but she is permanently confined to a wheelchair, unable to care for herself or her family.

While plaintiff was in St. Mary’s Hospital, extensive tests, etc. were carried on to determine the cause of her condition. Finally, a diagnosis of three separate but simultaneously existing diseases was made, two of them obvious and existing long before her admission to the hospital: (1) her rheumatoid arthritis; (2) a condition called Cushing’s Syndrome, *779 which is a recognized reaction to the cortisone drugs which she had been taking for many years (as indicated above, plaintiff contracted arthritis about 1945; she already exhibited some of the symptoms of Cushing’s Syndrome when she first saw Dr. Norman in 1956); and (3) vasculitis, 3 the disease which is the crux of this controversy.

Vasculitis, briefly, is an inflammation of the small blood vessels which causes them to swell so that the blood vessels are blocked and the area they supply is, therefore deprived of circulation. The symptoms of vasculitis are profound changes in the nerves supplied by the inflamed blood vessels, especially those going to the extremities, and weakness and loss of sensation in those areas supplied by the nerves supplied by the inflamed blood vessels, as well as by areas of skin destruction and gangrene. The disease is a rare one and there are several distinct types. The exact cause of vasculitis is unknown but is thought to be related to an allergic reaction of some kind. Some types of vasculitis develop as a complication of arthritis; others can be caused by certain drugs, including sulfa drugs as well as streptomycin, Chloromycetin and penicillin, and there has been a statistically high frequency of some types in persons on steroid therapy.

At the University of California Hospital, where plaintiff remained for a month after transfer from St. Mary’s Hospital, the previous diagnosis of three simultaneous conditions superimposed on each other was confirmed. Further courses of diagnosis and treatment were undertaken. A biopsy indicated acute inflammation of the blood vessels (vasculitis) and an inflammation of the muscles (myositis); there were also indications of central nervous system changes with some reflex disturbances.

The defendants’ medical experts agreed with the above mentioned diagnosis of plaintiff’s condition as well as the nature and causes of vasculitis.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

People v. Foalima
239 Cal. App. 4th 1376 (California Court of Appeal, 2015)
Rutherford v. Owens-Illinois, Inc.
941 P.2d 1203 (California Supreme Court, 1997)
Mitchell v. Gonzales
819 P.2d 872 (California Supreme Court, 1991)
Maupin v. Widling
192 Cal. App. 3d 568 (California Court of Appeal, 1987)
John B. Gunn Law Corp. v. Maynard
189 Cal. App. 3d 1565 (California Court of Appeal, 1987)
Kyriss v. State
707 P.2d 5 (Montana Supreme Court, 1985)
McGee v. Cessna Aircraft Co.
139 Cal. App. 3d 179 (California Court of Appeal, 1983)
Allen v. Sundean
137 Cal. App. 3d 216 (California Court of Appeal, 1982)
Vecchione v. Carlin
111 Cal. App. 3d 351 (California Court of Appeal, 1980)
Hart v. Browne
103 Cal. App. 3d 947 (California Court of Appeal, 1980)
Fraijo v. Hartland Hospital
99 Cal. App. 3d 331 (California Court of Appeal, 1979)
Barton v. Owen
71 Cal. App. 3d 484 (California Court of Appeal, 1977)
McQuillan v. Southern Pacific Co.
40 Cal. App. 3d 802 (California Court of Appeal, 1974)
Greenfield v. Insurance Inc.
19 Cal. App. 3d 803 (California Court of Appeal, 1971)
Estate of Rowley
257 Cal. App. 2d 324 (California Court of Appeal, 1967)
Norton v. Bunnell
257 Cal. App. 2d 324 (California Court of Appeal, 1967)
Dunlap v. Marine
242 Cal. App. 2d 162 (California Court of Appeal, 1966)
McDonald v. Schwartz
239 Cal. App. 2d 900 (California Court of Appeal, 1966)

Cite This Page — Counsel Stack

Bluebook (online)
235 Cal. App. 2d 775, 45 Cal. Rptr. 642, 1965 Cal. App. LEXIS 975, Counsel Stack Legal Research, https://law.counselstack.com/opinion/thomsen-v-rexall-drug-chemical-co-calctapp-1965.